PANX1 and neuroblastoma: Additionally, in high-risk neuroblastoma, inhibition of Panx1 channels using carbenoxolone and probenecid halted cell proliferation and reduced tumor growth, highlighting the therapeutic potential of Panx1 blockade in this pediatric cancer (63).